Neuronetics (STIM) Return on Capital Employed (2018 - 2026)

Neuronetics (STIM) has 9 years of Return on Capital Employed data on file, last reported at 27.96% in Q1 2026.

• On a quarterly basis, Return on Capital Employed rose 525.0% year-over-year to 27.96% in Q1 2026; TTM through Mar 2026 was 27.96%, a 525.0% increase from a year earlier, with the FY2025 full-year figure at 28.4%, up 720.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 27.96%, roughly flat from 27.82% in the prior quarter.
• Over the last five years, Return on Capital Employed for STIM reached as high as 25.16% in Q1 2022 and fell as low as 45.34% in Q4 2024.
• Historically, Return on Capital Employed has averaged 35.18% across 5 years, with a median of 35.74% in 2022.
• Across the five-year window, Return on Capital Employed sank 1958 bps in 2022 and surged 1751 bps in 2025, its largest moves.
• Year by year, Return on Capital Employed stood at 41.38% in 2022, then increased by 13 bps to 36.12% in 2023, then slipped by 26 bps to 45.34% in 2024, then jumped by 39 bps to 27.82% in 2025, then retreated by 0 bps to 27.96% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 27.96% in Q1 2026, 27.82% in Q4 2025, and 34.08% in Q3 2025.